Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial.
Yoshioka T, Takahashi M, Sakamoto Y, Okita A, Fukui T, Murakawa Y, Shindo Y, Imai H, Ohori H, Shirota H, Chiba N, Sasahara YI, Nomura T, Fukushima N, Yamaguchi T, Shimodaira H, Ishioka C.
Yoshioka T, et al. Among authors: fukushima n.
Anticancer Res. 2022 Apr;42(4):2009-2015. doi: 10.21873/anticanres.15680.
Anticancer Res. 2022.
PMID: 35347022
Clinical Trial.